Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit.

International Journal of Clinical Pharmacy
Richard S Bourne, Chui Lynn Choo

Abstract

Specific data on the actual clinical practice of United Kingdom pharmacists in Critical Care are limited. Within the general critical care units of Sheffield Teaching Hospitals, clinical pharmacists have the facility to electronically document, communicate and follow-up proactive recommendations using a Pharmacy Review Form via the Clinical Information System, MetaVision(®). The objective of the service evaluation was to describe the acceptance rate by medical staff of pharmacist proactive medication recommendations; including data on the types of recommendations and reasons thereof, for general intensive care patients of a UK teaching hospital trust. Sheffield Teaching Hospitals National Health Service Foundation Trust with 20 intensive care beds located on two hospital sites admitting Level 3 and 2 mixed general medical, surgical, trauma, burns and haematology/ oncology patients. Retrospective analysis of pharmacist proactive recommendations recorded electronically from January 2009 to July 2011 in general intensive care unit patients. Main outcome 5,623 electronic medication recommendations were documented, providing an average of 2.2 proactive recommendations per patient admitted to intensive care from January 2009 to July ...Continue Reading

References

Feb 15, 1997·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·N D BarberD A Ridout
Apr 9, 2001·Critical Care Medicine·K H IbrahimJ C Rotschafer
Feb 4, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Armen I Simonian
Dec 24, 2003·Pharmacy World & Science : PWS·Syed Tabish Razi ZaidiSeiw Hain Ng
Jan 13, 2006·BMC Medical Informatics and Decision Making·Elske AmmenwerthCornelia Mahler
Feb 17, 2006·Intensive Care Medicine·Michael Hartmann, Andreas Meier-Hellmann
Jun 3, 2006·Intensive Care Medicine·Gourang Patel, Mira Loh-Trivedi
Nov 8, 2007·Intensive Care Medicine·Jaclyn M LeBlancJoseph F Dasta
Nov 22, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Brian J KoppJeremiah J Duby
Aug 16, 2008·Shock·Flavia R Machado, Flávio G R Freitas
Nov 26, 2008·Critical Care : the Official Journal of the Critical Care Forum·Cecily MorrisonAlain Vuylsteke
Mar 14, 2009·BMJ : British Medical Journal·Andreas ValentinUNKNOWN Sentinel Events Evaluation (SEE) Study Investigators
May 12, 2009·Seminars in Dialysis·Mariann D Churchwell, Bruce A Mueller
Oct 6, 2010·Critical Care : the Official Journal of the Critical Care Forum·Joanna E KlopotowskaSusanne M Smorenburg
Aug 13, 2011·International Journal of Clinical Pharmacy·Richard S Bourne, Ben J Dorward

❮ Previous
Next ❯

Citations

Jul 21, 2012·Journal of the American Medical Informatics Association : JAMIA·Lena MamykinaGeorge Hripcsak
Jun 15, 2013·The International Journal of Pharmacy Practice·Richard S BourneBen J Dorward
Oct 1, 2015·The International Journal of Pharmacy Practice·Richard S BourneMark Borthwick
Apr 24, 2016·Journal of the American Medical Informatics Association : JAMIA·Scott D NelsonCharlene Weir
Jun 17, 2016·International Journal of Clinical Pharmacy·Ellen S KosterMarcel L Bouvy
Aug 26, 2016·Hospital Pharmacy·Tyler SledgeWayne Shipley
Sep 3, 2013·Current Opinion in Critical Care·Andreas Valentin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.